How Long Do Reconstituted Peptides Last? What Stability Studies Actually Measured
Last updated: October 28, 2026 · 8 min read · By the Grey Peptides Editorial Board
- There is no single shelf life for a mixed peptide. Fourteen approved labels read for this guide allow anywhere from 3 hours to 60 days, depending on the drug and its formulation.
- The '30 days' figure matches no general rule. The nearest rule is CDC's 28 days for an opened multi-dose vial from a manufacturer, unless the manufacturer states another date 1; for a drug dissolved in bacteriostatic water, the water's label says to use it promptly 2.
- Protein drugs are often made into freeze-dried solids to reach an acceptable shelf life, according to a review of solid protein drugs; the labels below give the dissolved forms far shorter periods than a powder's expiry date.
- A pen's in-use period, such as semaglutide's 56 days after first use, belongs to that pen's formulation. It says nothing about a vial of the same molecule mixed at home.
The 30-day answer, and why it has no source
The figure this page tests is a month, sometimes 28 days, sometimes 30, for a peptide mixed in a vial. It is not a general rule, and the labels of approved peptide drugs, which state a period for each specific product, show why.
The closest real rule is about vials, not peptides. CDC's injection-safety guidance, which concerns multi-dose vials labelled as such by their manufacturer, says that once such a vial from a manufacturer is opened it "should be dated and discarded within 28 days unless the manufacturer states another date for that opened vial" 1. For a drug dissolved in bacteriostatic water, the water's own label is stricter: "When diluting or dissolving drugs, mix thoroughly and use promptly. Do not store reconstituted solutions of drugs for injection unless otherwise directed by the manufacturer of the solute" 2. Our guide to bacteriostatic water explains where that comes from. It is a default for a preserved vial when a label is silent, not a measurement of how long any drug stays potent once it is dissolved.
Where manufacturers do state a period, the answers are nowhere near uniform. The labels below run from a few hours to two months.
Why peptides come as powder
Many injectable peptides that need mixing arrive as a freeze-dried powder (the first table below). A review of solid protein drugs gives the reason for proteins: because of their limited physical and chemical stability, proteins often have to be made into solid forms to achieve an acceptable shelf life, and freeze-drying, or lyophilization, is the most common way to do it 3. The same review notes that freeze-drying is not gentle. Freezing and drying both stress the molecule, and even a successfully dried protein may have limited long-term stability 3.
A review of protein drug stability, an update of a widely referenced 1989 review, discusses two broad kinds of failure, chemical and physical instability, and treats stabilisation in solution and in the dried state as separate subjects 4. Both reviews are about proteins; neither tested small peptides, which is why each product's own label period matters.
That is why the useful question is not how long a peptide lasts, but how long a particular solution, made a particular way, was shown to last. Only testing of that product can answer it.
What the labels measured: hours to two months
The table gathers the in-use periods printed on the labels of ten approved products that start as powder or ready-made vials. Each period is the label's own wording, condensed; the evidence grade links to the drug's encyclopedia entry.
| Drug (product) | What you start with | How long the label allows | Evidence grade |
|---|---|---|---|
| Teduglutide (Gattex) | Powder mixed with sterile water | Give within 3 hours of mixing 5 | High |
| Vosoritide (Voxzogo) | Powder mixed with the diluent supplied | Up to 3 hours in the vial at room temperature 6 | High |
| Rusfertide (Mimrylo) | Powder for reconstitution | As soon as possible, and no later than 4 hours 7 | High |
| Lonapegsomatropin (Skytrofa) | Cartridge reconstituted in its device | Within 4 hours at room temperature 8 | High |
| Tesamorelin (Egrifta SV) | Powder mixed with sterile water | Immediately; do not refrigerate or freeze the mixed solution 9 | High |
| Tesamorelin (Egrifta WR) | Powder mixed with bacteriostatic water | Discard 7 days after mixing 10 | High |
| Elamipretide (Forzinity) | Ready-made solution in vials | Discard vials 8 days after first opening 11 | High |
| Follitropin alfa (Gonal-f multi-dose) | Powder mixed with bacteriostatic water | The label: discard unused solution after 28 days 12 | High |
| Somatropin (Humatrope) | Reconstituted cartridge | Up to 28 days refrigerated 13 | High |
| Chorionic gonadotropin (Pregnyl) | Powder for reconstitution | Stable for 60 days refrigerated 14 | High |
Three things stand out. First, the spread: teduglutide and vosoritide allow about 3 hours, follitropin alfa and somatropin 28 days, and one chorionic gonadotropin product 60 days in the fridge 5 6 12 13 14. Second, four of the ten labels allow no more than 4 hours after mixing 5 6 7 8. Third, tesamorelin appears twice. Mixed with sterile water in its single-dose form, it is to be used at once and the solution is not to be refrigerated; mixed with bacteriostatic water in its multi-dose form, it lasts 7 days 9 10. Same molecule, same company, two answers, because the formulation and the diluent differ.
Each is the period printed on that product's label, approved with it. None of them is a general rule for the molecule, let alone for peptides as a class.
Pens are a different question
The other common reference point is the injection pen, and pens can last a long time after first use. The labels read for this guide give these periods:
| Drug (product) | What you start with | How long the label allows | Evidence grade |
|---|---|---|---|
| Teriparatide (Forteo) | Ready-to-use pen | Discard 28 days after first use 15 | High |
| Liraglutide (Victoza) | Ready-to-use pen | 30 days after first use, at room temperature or refrigerated 16 | High |
| Semaglutide (Wegovy FlexTouch) | Ready-to-use multi-dose pen | 56 days after first use, at 15-30 °C or refrigerated 17 | High |
| Tirzepatide (Mounjaro single-dose pen) | Ready-to-use single-dose pen | Up to 21 days in total out of the fridge, at no more than 30 °C 18 | High |
These are the periods the labels state 15 16 17 18. Each is stated for that product: semaglutide's 56 days belongs to the Wegovy FlexTouch pen, not to semaglutide 17. A powder of the same molecule, mixed in a vial, has no label period at all.
The tirzepatide row shows another distinction the labels draw: time out of the fridge is counted separately from time after first use. Its single-dose pens may spend up to 21 days in total at no more than 30 °C before use 18. Wegovy's single-dose pens and syringes may be kept at 8 to 30 °C for up to 28 days before the cap is removed 17. Those allowances are for unopened products, not for anything mixed.
Heat, cold and freezing
Refrigeration is the usual instruction, but it is not universal. Egrifta SV's label says the mixed solution should not be refrigerated or frozen; it is meant to be used at once 9. Several of the short periods in the first table are explicitly room-temperature periods 6 7 8. The label, not habit, decides where a mixed solution goes.
Where labels allow unopened pens out of the fridge, they set a ceiling of 30 °C and a maximum number of days 18 17.
Freezing deserves particular caution. The freeze-drying review describes freezing as one of the stresses that can denature proteins during manufacture, even with stabilisers present 3. Labels that address it tell users not to freeze the product 5 9 14 16.
What you can and cannot see
Labels ask users to look before injecting. The tesamorelin labels, for example, say to use the mixed solution only if it is clear, colourless and free of particles 9 10. Cloudiness, colour or flecks are reasons to discard.
The reverse is not established: the labels ask for a visual check, but none says a clear solution is still potent.
What this means for unapproved peptides
Every period in this guide comes from a label approved with a specific product and formulation. Peptides sold for "research use" have no approved label, so no label states an in-use period, storage temperature or diluent for them.
The labels and reviews allow a few general conclusions. Proteins are made into solids to achieve an acceptable shelf life 3. Label periods for approved peptides vary more than a hundredfold, so no single figure can be applied to an untested one. The formulation and the diluent change the answer even for the same molecule 9 10. And CDC's 28 days is for an opened multi-dose vial from a manufacturer 1; for a vial mixed from an unlabelled peptide, the bacteriostatic water label says to use the solution promptly and not to store it 2, and 28 days is at most an outer limit, not a time it has been shown to keep.
For mixing arithmetic, the site's reconstitution calculator and reconstitution guide cover volumes and concentrations. For what independent laboratories have found in products sold online, see independent lab results. None of this is medical advice; for anything you would inject, a pharmacist or clinician who can see the product's own documentation is the person to ask.
Frequently asked questions
How long do peptides last after reconstitution?
It depends on the product. Approved labels allow anywhere from about 3 hours (teduglutide, vosoritide) to 28 days (follitropin alfa, somatropin) and, for one chorionic gonadotropin product, 60 days refrigerated.
Is 30 days a safe rule for mixed peptides?
No label supports it as a general rule. The nearest rule is CDC's 28 days for an opened multi-dose vial from a manufacturer, unless the manufacturer states another date; the bacteriostatic water label says a drug dissolved in it should be used promptly and not stored unless the drug's maker directs otherwise, and label periods for approved peptides vary more than a hundredfold.
Do peptides need to be refrigerated after mixing?
Usually, but not always: one tesamorelin product's label says not to refrigerate or freeze the mixed solution and to use it at once. The product's label decides.
Do peptides expire before mixing?
Yes. Unopened products carry an expiry date, and proteins are often freeze-dried to reach an acceptable shelf life, though even dried proteins may have limited long-term stability.
Why does a semaglutide pen last 56 days?
Because that pen's label states it: after first use the Wegovy FlexTouch pen can be kept for 56 days at 15-30 °C or refrigerated. The period belongs to that pen, not to semaglutide powder mixed in a vial.
Can you tell if a mixed peptide has gone off?
Only partly. Labels say to discard a solution that is cloudy, coloured or has particles; none says a clear solution is still potent.
Related on Grey Peptides
- Bacteriostatic water: approved products, how long a vial lasts, cost
- How to Reconstitute Peptides
- Reconstitution calculator
- Independent lab results
Sources
- Centers for Disease Control and Prevention. Preventing Unsafe Injection Practices (Injection Safety: clinical safety; last reviewed March 26, 2024). Read October 27, 2026. CDC
- Hospira, Inc.. Bacteriostatic Water for Injection, USP. Prescribing information, DailyMed set 87d6e9dc-fe3b-4593-ac9a-d7493d1959c7, version 20, effective 2026-05-22; read October 27, 2026. DailyMed
- Wang, W. (2000). Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. PMID: 10967427
- Manning, M. C. et al. (2010). Stability of protein pharmaceuticals: an update. Pharm Res. PMID: 20143256
- Takeda Pharmaceuticals America. Gattex (teduglutide) for injection. Prescribing information, DailyMed set 66b69c1e-b25c-44d3-b5ff-1c1de9a516fa, version 20, effective 2025-09-05; read October 27, 2026. DailyMed
- BioMarin Pharmaceutical. Voxzogo (vosoritide) for injection. Prescribing information, DailyMed set 228e8560-04a4-4bb1-a81f-29531a9e4d27, version 16, effective 2025-11-25; read October 27, 2026. DailyMed
- Takeda Pharmaceuticals America. Mimrylo (rusfertide). Prescribing information, DailyMed set 101aff01-31ed-4841-a8b6-0a5a8503189b, version 2, effective 2026-08-28; read October 27, 2026. DailyMed
- Ascendis Pharma. Skytrofa (lonapegsomatropin-tcgd) for injection. Prescribing information, DailyMed set 9229f871-bc61-4ddc-8122-d126d40e36ac, version 14, effective 2026-10-21; read October 27, 2026. DailyMed
- Theratechnologies Inc.. Egrifta SV (tesamorelin for injection). Prescribing information, DailyMed set 3d783378-b02d-4f19-99dd-0fc91a042224, version 9, effective 2026-07-29; read October 27, 2026. DailyMed
- Theratechnologies Inc.. Egrifta WR (tesamorelin for injection). Prescribing information, DailyMed set 839334d3-8c1d-4c26-9036-2ab524a6ea75, version 2, effective 2026-07-29; read October 27, 2026. DailyMed
- Stealth BioTherapeutics. Forzinity (elamipretide) injection. Prescribing information, DailyMed set 146bf34c-76f2-48db-ac07-fb29cce2cd75, version 10, effective 2025-12-10; read October 27, 2026. DailyMed
- EMD Serono. Gonal-f (follitropin alfa for injection). Prescribing information, DailyMed set ae85b9c3-e7eb-4981-a5d9-346050e8f189, version 15, effective 2025-09-02; read October 27, 2026. DailyMed
- Eli Lilly and Company. Humatrope (somatropin) for injection. Prescribing information, DailyMed set a774e1ae-3997-49ee-8b0e-99a2b315d409, version 45, effective 2026-08-20; read October 27, 2026. DailyMed
- Organon LLC. Pregnyl (chorionic gonadotropin for injection). Prescribing information, DailyMed set 1e94155f-19be-4944-b197-be4edbb4faf9, version 11, effective 2025-12-02; read October 27, 2026. DailyMed
- Eli Lilly and Company. Forteo (teriparatide) injection. Prescribing information, DailyMed set aae667c5-381f-4f92-93df-2ed6158d07b0, version 44, effective 2026-08-03; read October 27, 2026. DailyMed
- Novo Nordisk. Victoza (liraglutide) injection. Prescribing information, DailyMed set 5a9ef4ea-c76a-4d34-a604-27c5b505f5a4, version 31, effective 2025-10-14; read October 27, 2026. DailyMed
- Novo Nordisk. Wegovy (semaglutide) injection. Prescribing information, DailyMed set ee06186f-2aa3-4990-a760-757579d8f77b, version 19, effective 2026-06-18; read October 27, 2026. DailyMed
- Eli Lilly and Company. Mounjaro (tirzepatide) injection. Prescribing information, DailyMed set d2d7da5d-ad07-4228-955f-cf7e355c8cc0, version 40, effective 2026-08-27; read October 27, 2026. DailyMed
Educational information, not medical advice. Each dose in this guide names its source, an approved label or a published study. None is a recommendation for you. An unapproved compound has no established safe or effective human dose, and products sold for “research use only” are not made or tested for people. Talk to a doctor before acting on anything on this site, including before you start, stop or change any medicine or dose. This guide reports what product labels and published reviews say; it does not name or link to any seller, and it is not medical advice.
New guides and rule changes, by email
One short email when a peptide's legal status moves — an FDA or PCAC decision, a WADA list change, an enforcement action — plus new guides and tools. At most one a week, and none when nothing changes. The newsletter has not started sending yet: your first email will be its first issue.
We keep your email address and the page you signed up from, nothing else. How it works · Privacy · RSS instead